Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
March Mildness: Familiar Faces And Standard Reviews On US FDA’s Scorecard
Mar 04 2026
•
By
Bridget Silverman
The FDA is reviewing 10 applications with March user fee goal dates.
(Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from US FDA Performance Tracker
More from Regulatory Trackers